ID 6D49A STANDARD; PRT; 127 AA. DT CONVERTED FROM PDB (SEQRES) 6D49 DE Myeloid cell surface antigen CD33 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 1.800 CC R-Factor 0.185 FT #SUB 19 35 LEU A 19 35 LEU B Protein S 1 FT #SUB 19 35 LEU A 20 36 CYS B Protein B 2 FT #SUB 20 36 CYS A 20 36 CYS B Protein A 7 FT #SUB 22 38 LEU A 75 91 ARG B Protein S 1 FT #SUB 75 91 ARG A 22 38 LEU B Protein S 1 FT #SUB 75 91 ARG A 24 40 PRO B Protein S 1 FT #SUB 77 93 LEU A 77 93 LEU B Protein S 1 FT #SUB 79 95 ASP A 82 98 ARG B Protein S 1 FT #SUB 82 98 ARG A 79 95 ASP B Protein S 4 FT #SUB 82 98 ARG A 82 98 ARG B Protein S 8 FT #SUB 88 104 SER A 22 38 LEU B Protein S 1 FT #SUB 90 106 VAL A 22 38 LEU B Protein S 1 FT #HET 2 18 ASP A 5 205 FVP A S 2 FT #HET 4 20 ASN A 5 205 FVP A S 2 FT #HET 5 21 PHE A 5 205 FVP A S 6 FT #HET 20 36 CYS A 2 202 GOL A A 5 FT #HET 21 37 VAL A 2 202 GOL A B 7 FT #HET 22 38 LEU A 2 202 GOL A B 2 FT #HET 32 48 PRO A 1 201 GOL A A 3 FT #HET 33 49 TYR A 1 201 GOL A A 5 FT #HET 34 50 TYR A 1 201 GOL A S 1 FT #HET 50 66 ILE A 5 205 FVP A S 1 FT #HET 51 67 ILE A 4 204 GOL A B 1 FT #HET 52 68 SER A 4 204 GOL A B 2 FT #HET 52 68 SER A 5 205 FVP A A 19 FT #HET 53 69 ARG A 4 204 GOL A B 2 FT #HET 54 70 ASP A 4 204 GOL A B 2 FT #HET 55 71 SER A 4 204 GOL A A 2 FT #HET 64 80 GLN A 4 204 GOL A S 3 FT #HET 77 93 LEU A 7 202 GOL B S 1 FT #HET 88 104 SER A 2 202 GOL A A 4 FT #HET 101 117 PHE A 5 205 FVP A S 4 FT #HET 103 119 ARG A 5 205 FVP A S 8 FT #HET 107 123 GLY A 3 203 GOL A B 1 FT #HET 108 124 SER A 3 203 GOL A A 3 FT #HET 110 126 LYS A 3 203 GOL A S 7 FT #HET 110 126 LYS A 5 205 FVP A A 8 FT #HET 111 127 TYR A 5 205 FVP A A 5 FT #HET 112 128 SER A 5 205 FVP A A 10 FT #HET 113 129 TYR A 5 205 FVP A B 2 FT #HET 114 130 LYS A 5 205 FVP A A 22 FT DISORDER 127 127 CC SEQUENCE 126 AA (ATOM); CC GDPNFWLQVQ ESVTVQEGLC VLVPCTFFHP IPYYDKNSPV HGYWFREGAI ISRDSPVATN CC KLDQEVQEET QGRFRLLGDP SRNNCSLSIV DARRRDNGSY FFRMERGSTK YSYKSPQLSV CC HVTDLT CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAI CC ATOM GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAI CC ************************************************** CC SEQRES ISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSY CC ATOM ISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSY CC ************************************************** CC SEQRES FFRMERGSTKYSYKSPQLSVHVTDLTH CC ATOM FFRMERGSTKYSYKSPQLSVHVTDLT- CC ************************** SQ SEQUENCE 127 AA; MW; CN; GDPNFWLQVQ ESVTVQEGLC VLVPCTFFHP IPYYDKNSPV HGYWFREGAI ISRDSPVATN KLDQEVQEET QGRFRLLGDP SRNNCSLSIV DARRRDNGSY FFRMERGSTK YSYKSPQLSV HVTDLTH // ID 6D49B STANDARD; PRT; 127 AA. DT CONVERTED FROM PDB (SEQRES) 6D49 DE Myeloid cell surface antigen CD33 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 1.800 CC R-Factor 0.185 FT #SUB 19 35 LEU B 19 35 LEU A Protein S 1 FT #SUB 20 36 CYS B 19 35 LEU A Protein S 2 FT #SUB 20 36 CYS B 20 36 CYS A Protein A 7 FT #SUB 22 38 LEU B 75 91 ARG A Protein S 1 FT #SUB 22 38 LEU B 88 104 SER A Protein S 1 FT #SUB 22 38 LEU B 90 106 VAL A Protein S 1 FT #SUB 24 40 PRO B 75 91 ARG A Protein S 1 FT #SUB 75 91 ARG B 22 38 LEU A Protein S 1 FT #SUB 77 93 LEU B 77 93 LEU A Protein S 1 FT #SUB 79 95 ASP B 82 98 ARG A Protein S 4 FT #SUB 82 98 ARG B 79 95 ASP A Protein S 1 FT #SUB 82 98 ARG B 82 98 ARG A Protein S 8 FT #HET 2 18 ASP B 11 206 FVP B S 2 FT #HET 5 21 PHE B 11 206 FVP B S 7 FT #HET 24 40 PRO B 7 202 GOL B A 2 FT #HET 32 48 PRO B 6 201 GOL B A 3 FT #HET 33 49 TYR B 6 201 GOL B S 1 FT #HET 34 50 TYR B 6 201 GOL B S 1 FT #HET 34 50 TYR B 11 206 FVP B S 1 FT #HET 49 65 ALA B 10 205 GOL B B 6 FT #HET 50 66 ILE B 10 205 GOL B B 1 FT #HET 51 67 ILE B 9 204 GOL B B 1 FT #HET 51 67 ILE B 10 205 GOL B A 6 FT #HET 52 68 SER B 9 204 GOL B B 2 FT #HET 52 68 SER B 11 206 FVP B A 16 FT #HET 53 69 ARG B 9 204 GOL B B 3 FT #HET 55 71 SER B 9 204 GOL B A 4 FT #HET 64 80 GLN B 9 204 GOL B S 7 FT #HET 65 81 GLU B 9 204 GOL B S 2 FT #HET 66 82 VAL B 8 203 GOL B S 1 FT #HET 71 87 GLN B 8 203 GOL B A 3 FT #HET 72 88 GLY B 8 203 GOL B B 1 FT #HET 77 93 LEU B 2 202 GOL A S 2 FT #HET 84 100 ASN B 7 202 GOL B S 4 FT #HET 86 102 SER B 7 202 GOL B S 3 FT #HET 88 104 SER B 2 202 GOL A S 3 FT #HET 101 117 PHE B 10 205 GOL B S 1 FT #HET 101 117 PHE B 11 206 FVP B S 4 FT #HET 103 119 ARG B 11 206 FVP B S 8 FT #HET 110 126 LYS B 11 206 FVP B A 8 FT #HET 111 127 TYR B 11 206 FVP B A 6 FT #HET 112 128 SER B 10 205 GOL B S 4 FT #HET 112 128 SER B 11 206 FVP B A 10 FT #HET 113 129 TYR B 11 206 FVP B B 1 FT #HET 114 130 LYS B 11 206 FVP B A 4 FT #HET 117 133 GLN B 11 206 FVP B S 2 FT DISORDER 127 127 CC SEQUENCE 126 AA (ATOM); CC GDPNFWLQVQ ESVTVQEGLC VLVPCTFFHP IPYYDKNSPV HGYWFREGAI ISRDSPVATN CC KLDQEVQEET QGRFRLLGDP SRNNCSLSIV DARRRDNGSY FFRMERGSTK YSYKSPQLSV CC HVTDLT CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAI CC ATOM GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAI CC ************************************************** CC SEQRES ISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSY CC ATOM ISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSY CC ************************************************** CC SEQRES FFRMERGSTKYSYKSPQLSVHVTDLTH CC ATOM FFRMERGSTKYSYKSPQLSVHVTDLT- CC ************************** SQ SEQUENCE 127 AA; MW; CN; GDPNFWLQVQ ESVTVQEGLC VLVPCTFFHP IPYYDKNSPV HGYWFREGAI ISRDSPVATN KLDQEVQEET QGRFRLLGDP SRNNCSLSIV DARRRDNGSY FFRMERGSTK YSYKSPQLSV HVTDLTH //